Biochemical changes in rat muscle tissue with prolonged use of simvastatin

Abstract

Aim. Analysis of biochemical changes in rat muscle tissue after prolonged use of simvastatin.

Methods. The study was conducted on mongrel male rats. Three groups were identified: control group (intact animals), comparison group (animals with induced hypercholesterolemia not reeciving the drugs), and experimental group (animals with induced hypercholesterolemia receiving simvastatin 0.0012 g/100 g of weight once a day for 2 months as an aqueous suspension through the esophageal probe). Metabolite concentration of glycolysis (pyruvic acid and lactate), activity of antioxidant protection enzymes (reduced glutathione, superoxide dismutase, catalase, glutathione reductase, glutathione peroxidase), titin isoforms and proteolytic fragments of titin and nebulin concentration were determined in the muscles of animals.

Results. After administration of simvastatin to animals with induced hypercholesterolemia, a decrease in the concentration of glycolysis metabolites (pyruvic acid and lactate) compared to comparison group was revealed, as well as multidirectional changes in the activity of antioxidant protection enzymes (decrease in activity of superoxide dismutase, glutathione peroxidase, and glutathione reductase, decreased concentration of reduced glutathione, but catalase activity remained unchanged). The analysis of structural changes in animal muscle tissue after administration of simvastatin revealed a decrease in the concentration of NT- and N2A-titin isoforms and practically complete absence of nebulin compared to the animals from the comparison group. At the same time an increase in the concentration of proteolytic fragments of titin (T2) by 1.3 times was recorded.

Conclusion. The study showed that the basis of myotoxicity of statins in their long-term use is disintegration of enzyme antioxidant processes, as well as tissue hypoxia, leading to destruction of muscle fibers and prevalence of proteolytic processes.

Keywords

atherosclerosis / statins / statin myopathy / simvastatin / skeletal muscles

References

[1] Mikashinovich Z.I., Belousova E.S., Vinogradova E.V., Semenets I.A. Еnzymatic antioxidant protection in muscles of rats under long-term administration of simvastatin. Meditsinskiy vestnik Bashkortostana. 2017; 12 (1): 54–57. (In Russ.)

[2] Микашинович З.И., Белоусова Е.С., Виноградова Е.В., Семенец И.А. Ферментативная антиоксидантная защита в мышцах крыс при длительном введении симвастатина. Мед. вестн. Башкортостана. 2017; 12 (1): 54-57.

[3] Mikashinovich Z.I., Belousova E.S. Impairment of energy-dependant processes in the muscle tissue as a pathogenetic mechanisms of statin-induced myopathy. Byulleten' eksperimental'noy biologii i meditsiny. 2016; 162 (10): 426–430. (In Russ.)

[4] Микашинович З.И., Белоусова Е.С. Нарушение энергозависимых процессов в мышечной ткани как один из патогенетических механизмов статиновой миопатии. Бюлл. эксперим. биол. и мед. 2016; 162 (10): 426-430.

[5] Kalinina E.V., Chernov N.N., Aleid R. et al. Current views of antioxidative activity of glutathione and glutathione-depending enzymes. Vestnik RAMN. 2010; 3: 46–54. (In Russ.)

[6] Калинина Е.В., Чернов Н.Н., Алеид Р. и др. Современные представления об антиоксидантной роли глутатиона и глутатионзависимых ферментов. Вестник РАМН. 2010; 3: 46-54.

[7] Mikashinovich Z.I., Letunovskiy A.V., Volzhin O.O., Belousova E.S. Biokhimicheskie issledovaniya slyuny v klinicheskoy praktike. (Biochemical studies of saliva in clinical practice.) Rostov-na-Donu: Izdatel'stvo RostGMU. 2004; 80 p. (In Russ.)

[8] Микашинович З.И., Летуновский А.В., Волжин О.О., Белоусова Е.С. Биохимические исследования слюны в клинической практике. Ростов-на-Дону: Изд-во РостГМУ. 2004; 80 c.

[9] Vikhlyantsev I.M., Podlubnaya Z.A. Titin isoform composition in the muscles in pathological processes. Biofizika. 2008; 53 (6): 1058–1065. (In Russ.)

[10] Вихлянцев И.М., Подлубная З.А. Изоформный состав тайтина в мышцах при патологических процессах. Биофизика. 2008; 53 (6): 1058-1065.

[11] Vikhlyantsev I.M., Podlubnaya Z.A. New titin (connectin) isoforms and their functional role in striated muscles of mammals: facts and suppositions. Uspekhi biologicheskoy khimii. 2012; 52: 239–280. (In Russ.)

[12] Вихлянцев И.М., Подлубная З.А. Новые изоформы тайтина (коннектина) и их функциональная роль в поперечнополосатых мышцах млекопитающих. Факты и предположения. Успехи биол. хим. 2012; 52: 239-280.

[13] Dubinina E.E. The role of reactive oxygen species as signal molecules in tissue metabolism under conditions of oxidative stress. Voprosy meditsinskoy khimii. 2001; 47 (6): 561–581. (In Russ.)

[14] Дубинина Е.Е. Роль активных форм кислорода в качестве сигнальных молекул в метаболизме тканей при состояниях окислительного стресса. Вопр. мед. хим. 2001; 47 (6): 561-581.

[15] Lakomkin V.L., Kapel'ko V.I., Lankin V.Z. et al. Effect of β-hydroxy-β-methylglutaryl coenzyme a reductase inhibitor atorvastatin on contractility of the isolated rat heart under normal conditions and during oxidative stress. Byulleten' eksperimental'noy biologii i meditsiny. 2007; 143 (4): 383–385. (In Russ.)

[16] Лакомкин В.Л., Капелько В.И., Ланкин В.З. и др. Влияние ингибитора β-гидрокси-β-метилглутарил-коэнзим-А-редуктазы аторвастатина на сократимость изолированного сердца крыс в норме и при окислительном стрессе. Бюлл. эксперим. биол. и мед. 2007; 143 (4): 383-385.

[17] Kulinskiy V.I., Kolesnichenko L.S. System of glutathione I. Synthesis, transport, glutathione transferases, glutathione peroxidases. Biomeditsinskaya khimiya. 2009; 55 (3): 255–277. (In Russ.)

[18] Кулинский В.И., Колесниченко Л.С. Система глутатиона I. Синтез, транспорт глутатионтрансферазы, глутатионпероксидазы. Биомед. хим. 2009; 55 (3): 255-277.

[19] Mikashinovich Z.I., Belousova E.S. Biochemical changes in erythrocytes as a molecular marker of cell damage during long-term simvastatin treatment. Kletochnye tekhnologii v biologii i meditsine. 2016; 2: 122–126. (In Russ.)

[20] Микашинович З.И., Белоусова Е.С. Биохимические изменения в эритроцитах как молекулярный индикатор клеточного повреждения при длительном введении симвастатина. Клеточные технол. в биол. и мед. 2016; 2: 122-126.

RIGHTS & PERMISSIONS

Vinogradova E.V.